Unbiased Analysis of Today's Healthcare Issues
How should you report the methodology, results and limitations of your economic model? One of the most commonly used approaches is the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. CHEERS was developed in 2013 (Husereau et al. 2013) and a new version has been developed this year (Husereau et al. 2022). Below are the…
Pharma bro: guilty. Douthat: “How Being Sick Changed My Health Care Views”. GAVI: $150m for malaria vaccine roll-out in sub-Saharan Africa Falling drug prices? Will CMS ban PBM direct and indirect remuneration (DIR) fees? Will Democrats deliver on their health care promises?
An interesting article in Modern Healthcare reviews some discussion at a recent Medicare Payment Advisory Commission (MedPAC) meeting. The first issue is that the pool of fee-for-service Medicare beneficiaries is shrinking, at least on a relative basis. As Medicare Advantage grows each year, population-based alternative payment models like accountable care organizations are left with a…
Over time, physicians are less likely to operate in solo or small group practices. In fact, the share of physician-owned practices has fallen below 50% in recent years. A key question then is how does a physician’s environment or the group they have join affect their practice patterns? Previous research has found that a physician’s…
There is mixed evidence about whether hospital mergers improve quality. On the one hand, economies of scale could lead to more investment in information technology, or allow for further specialization of services. A recent paper by Wang et al. (2022) investigates the impact of a recent hospital merger on quality in New York. The merging…
Supreme court blocks broad COVID-19 vaccine mandate. Trends in geographic variation in Medicare spending. ACA and marriage. Medicare Advantage hospice carve-in? Ethnic disparities in ED wait times.
My colleagues at FTI have a new white paper out surveying health care leaders on trends to expect in 2022. The data come from a survey of 251 senior decision makers working in corporate communications, investor relations, public affairs, business development, R&D and marketing for healthcare and life sciences companies in the U.S. Some key…
The policy rationale for disability insurance is sensible. If you are disabled (either in the short-run or long-run) and unable to work, government support is highly beneficial in reducing inequality. Whereas other policies to redistribute income (e.g., welfare, unemployment insurance) may reduce inequality, they also may have the unintended consequences of reducing incentives to work.…
In 2021, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 50 new drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs), or as new therapeutic biologics under Biologics License Applications (BLAs). FDA summarizes these approvals in their recently released report titled: Advancing Health Through Innovation: New Drug…